請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30615
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江福田(Fu-Tien Chiang) | |
dc.contributor.author | Cho-Kai Wu | en |
dc.contributor.author | 吳卓鍇 | zh_TW |
dc.date.accessioned | 2021-06-13T02:10:15Z | - |
dc.date.available | 2007-08-08 | |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-06-26 | |
dc.identifier.citation | 1. Anna FC, Bleumink GS, Bruno HCH, et al. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects European Heart Journal (2004) 25, 2143-8
2. Angeja BG, Grossman W. Evaluation and Management of Diastolic Heart Failure Circulation 2003; 107: 659-63 3. Aurigemma GP, Gaasch WH. Diastolic Heart failure. NEJM 2004; 351; 11: 1097-105 4. Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin II Type I Receptor Gene Polymorphisms in Human Essential Hypertension Hypertension 1994; 24:63-9 5. Brilla CG, Pick R, Tan LB, et al. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990: 67: 1355 - 64 6. Bleumink GS, Anna FC. Schut,.JM, et al. Genetic polymorphisms and heart failure Genetics in Medicine 2004, (6): 465-72 7. Chaves FJ, Pascual JM, Rovira E, et al. Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension Am J Hypertens. 2001 ;14(4 Pt 1):364-70 8. Chiang FT, Hsu KL, Tseng CD, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens. 1997 ;15(6):607-11 9. Chiang FT, Lai ZP, Chern TH, et al. Lack of association of the angiotensin converting enzyme gene polymorphism with essential hypertension in a Chinese population. Am J Hypertens 1997;10:197-201 10. Devereux RB, Danieln RA, Elizabeth ML, et al. Am J Cardiol 1986,57:450-8 11. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003 12. Friedrich SP, Lorell BH, Rousseau MF, et al. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation. 1994; 90: 2761–71 13. Flesch M, Schiffer F, Zolk O, et al. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens. 1997; 15: 1001–9 14. Goette A, Staack T, Röcken C, et al. Increased expression of extracellular-signal regulated kinases and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol. 2000;35:1669–77 15. Gaillard I, Clauser E, Corvol, P. Structure of Human Angiotensinogen Gene. DNA 1989;8(2):87-99 16. Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound. 2005, 3(1):9-11. 17. Goldbergova M, Spinarova L, Spinar J, et al. Association of two angiotensinogen gene polymorphisms, M235T and G-6A, with chronic heart failure. Int Journal of Cardiol 2003, 89, 267-72 18. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 2004;55:373-94 19. Henskens LH, Spiering W, Stoffers HE, et al. Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocrates study. J Hypertens 2003; 21:81-86 20. Hanatani A, Yoshiyama M, Kim S, et al. Inhibition by angiotensin II type I receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol. 1995; 27: 1905–14 21. Hilgers KF, langenfeld MR, Schlaich M, et al. 1166A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II. Circulation 1999:100 ,1394-99 22. Hindorff LA, Heckbert SR, Tracy R, et al. Angiotensin II type I receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Health 2002; 15:1050-6 23. Hunt SA, Baker DW, Chin MH, et al. Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101-13 24. Huang W, Xie C, Zhou H, et al. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients The European Journal of Heart Failure 2004(6): 23-7 25. Ju H, Fleur TS, Ian MC. Dixon Altered mRNA Abundance of Calcium Transport Genes in Cardiac Myocytes Induced by Angiotensin II J Mol Cell Cardiol 1996, 28, 1119–28 26. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular Basis of Human Hypertension: Role of Angiotensinogen Cell 1992, 71, 169-80 27. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991 Oct 11;19:5444 28. McNamara DM, Holubkov R, Postava L, et al. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure J Am Coll Cardiol 2004, (44),10, 2019-26 29. Miller JA, Scholey JW. The impact of rennin-angiotensin system polymorphisms on physiological and pathological process in humans. Current Opinion in Nephrology and Hypertension 2004,13:101-6 30. Oh JK, Hatle A, Tajik AJ, et al. Diastolic Heart Failure Can Be Diagnosed by Comprehensive Two-Dimensional and Doppler Echocardiography. J Am Coll Cardiol 2006,47,3:500-6 31. Patel DA, Li S, Chen W, et al. G-6A polymorphism of the angiotensinogen gene and its association with left ventricular mass in asymptomatic young adults from a biethnic community: the Bogalusa Heart Study. Am J Hypertens 2005;18:1437-41 32. Reich H, Duncun JA, Weinstein J, et al. Interactions between gender and the angiotensin type I receptor gene polymorphism. Kidney Int 2003; 63:1443-9 33. Sanderson JE, Yu CM, Young, RD, et al. Influence of gene polymorphisms of the renin-angiotensin system on clinical outcome in heart failure among the Chinese Am Heart J 1999; 137:653-7 34. Tsai CT, Fallin D, Chiang FT, et al. Angiotensinogen Gene haplotype and hypertension interaction with ACE gene I Allele. Hypertension. 2003; 41:9-15 35. Takahashi N, Murakami H, Kodama K, et al. Association of a polymorphism at the 5'-region of the angiotensin II type 1 receptor with hypertension. Ann hum Genet 64, 197-205 36. Urata H, Boehm KD, Philip A, et al. Cellular localization and regional distribution of an angiotensin II- forming chymase in the heart. J Clin Invest 1993;91:1269-81. 37. Vasan R, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55 38. Van Der Kleij FGH, De Jong PE, Henning RH, et al. Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake. J Am Soc Nephrol 2002; 13:1025-1033. 39. Weber KT, Brilla CG, Griendling KK, et al. Myocardial fibrosis functional significance and regulatory factors. Cardiovas Res,1993;27:341-8 40. Weber KT, Sun Y, Tyagi SC, et al. Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Moll Cell Cardiol 1994;26:279-92 41. Zaykin DV, Westfall PH, Young SS, et al. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individual. Hum Hered 53:79-91 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30615 | - |
dc.description.abstract | 心臟衰竭是許多心臟疾病末期的表徵,同時也是全球統計上名列前茅的死因。至於心臟的舒張性功能障礙指的是左心室在舒張期的膨脹,填充,舒張出現了異常。統計上心衰竭的病人有1/2~1/3屬於舒張性心衰竭(diastolic heart failure),每年的死亡率約為5~8% [Aurigemma-2004],但臨床上對於診斷或者是治療往往都因沒有治療終點而輕忽。
導致舒張性心衰竭的原因包括心肌舒張不良,心肌硬化增加,心包膜疾病,心肌疾病,以及各種激素,收縮素的影響….等等[Brad-2003]。在各種致病因中,可以在臨床上用藥物來調節的便是腎素-血管激素系統。腎素 - 血管收縮素系統是我們體內調控血壓的系統,除了可以讓鈉和水分留在體內,也可以讓細胞增生,血管增厚。研究報告顯示,它也和高血壓病患產生心臟肥大[Brilla-1990],心臟衰竭[Webber-1993],心肌梗塞[Hanatani-1995],心肌症[Urata-1993],以及心房振顫[Goette-2000]有關。 實驗證明,腎素血管激素系統和SERCA(sarcoplasmic reticulum calcium ATP-ase pump)的調節有關,而血管收縮素阻斷劑更可以透過調控SERCA的多寡影響到心臟的舒張功能。臨床上腎素血管收縮素系統基因的多型性證明和心肌局部的SERCA濃度相關。因此,我們假設腎素-血管收縮素系統基因可能是舒張性心衰竭的易感受基因(susceptible gene),進一步希望能分析藥物對基因型的影響。 我們用臨床症狀,以及心臟超音波的表徵來定義出舒張性心衰竭的病患。抽取病人的去氧核醣核酸 (DNA),並檢測血管收縮素轉化酵素基因的插入/缺失(ACE gene insertion/deletion)多型性、血管收縮素原 (angiotensinogen)的T174M、M235T、G-6A、A-20C、G-152A、G-217A等六處基因的多型性,以及血管收縮素II的第一型接受器基因 (angiotensin II type I receptor)的A1166C多型性。研究這些基因是否與舒張性心衰竭有關,並且使用組合多基因型方法 (Composite Haplotype Method)來做haplotypes的分析,希望能找到相關的基因,進而評估基因對於藥物的反應。 此研究包括148位舒張性心衰竭的患者以及148位對照組,對照組和實驗組根據性別、年齡採用一對一的方式選取,單基因座的分析發現血管收縮素轉化酵素基因的插入/缺失多型性以及血管收縮素II的第一型接受器基因的A1166C多型性會增加患病的感受性,勝算比 (Odds Ratios)分別為2.37 (95%信賴區間為1.33至4.22,P=0.003)以及4.44 (95%信賴區間為1.81至10.9, P=0.001)。在血管收縮素原的多基因座單套型 (Multilocus haplotype)分析中發現有兩種基因單套型在舒張性心衰竭和對照組有顯著的差異。擁有G-A-A-A-T-C以及A-G-A-G-C-C這兩種單倍型對於舒張性心衰竭的感受性較高,其P值分別為<0.005以及<0.05。 我們證實了腎素-血管收縮素系統基因多型性與舒張性心衰竭的關聯,也提供未來利用腎素-血管收縮素阻斷劑來治療舒張性心衰竭臨床實驗的一個很好的依據。 | zh_TW |
dc.description.abstract | Objectives: We analysis the renin-angiotensin system(RAS) genes and determine the association between single locus RAS genes polymorphisms, and multilocus AGT gene polymorphisms and gene-gene interaction with diastolic heart failure(DHF).
Background: DHF refers to an abnormality of diastolic distensibility, filling, or relaxation of the left ventricle. Pathology leading to DHF include impaired relaxation, increased passive stiffness, endocardial and pericardial disorders, microvacular flow and neurohormonal regulation. Among them, the association of RAS system and diastolic dysfunction are already established. There are many reports demonstrating the association of RAS system genes polymorphisms with congestive heart failure, but to what extent they affect DHF remains uncertain. We hypothesized that RAS gene might be the susceptible gene for DHF and conducted a case-control study with this regard. Method: The definition of DHF is according to guidelines from the ACC and AHA which include typical symptoms and signs of heart failure, normal left ventricle(LV) ejection fraction, evidence of LV impaired relaxation under echocardiography. Exclusion criteria include coronary artery disease, significant valvular heart disease, cardiomyopathy, pericardial disease and renal insufficiency. A total of 148 patients with DHF and 148 controls were included. The controls were matched to cases on a 1-to-1 basis with regard to age, gender, diabetes mellitus, hypertension. The ACE gene insertion/deletion polymorphism, the T174M, M235T, G-6A, A-20C, G-152A and G-217A polymorphisms of the angiotensinogen gene and the A1166C polymorphisms of the angiotensin II type I receptor gene were genotyped. Differences in allele frequencies and genotype distributions between the DHF and control group patients were compared using the χ2 test or the Fisher exact test. Mutilocus haplotypes analysis and gene-gene interaction analysis were performed by composite haplotype method of Zaykin et al. Results In single-locus analysis, ACE gene DD genotype, the angiotensin II type I receptor A1166C gene CC genotype were significantly associated with higher incidence of DHF. The odds ratio for DHF were 2.37 (95% CI 1.33 to 4.22, p=0.003) with ACE DD genotype, 4.44 (95% CI 1.81 to 10.9, p=0.001) with 1166CC plus 1166AC genotype. In addition, two angiotensinogen gene haplotype frequencies (GAAATC, AGAGCC) were significantly different between DHF group and the controls. There were obvious gene-gene interaction between ACE I/D and AGT A-20C, T174M in determing DHF. Conclusions This study confirmed an association of RAS gene polymorphisms with DHF. ACE DD and AT1R 1166 AC/CC genotypes conferred risk for DHF. We first demonstrate that AGT haplotype is associated with DHF. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T02:10:15Z (GMT). No. of bitstreams: 1 ntu-96-P94421002-1.pdf: 471981 bytes, checksum: d1f0ae130d4e2b8795499f88243d3053 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 致謝 ………………………………………………………………………I
目錄 ……………………………………………………………………II 表目錄 …………………………………………………………………III 圖目錄 …………………………………………………………………IV 第一章 中文摘要…………………………………………………………1 第二章 緒論………………………………………………………………3 第一節 研究背景………………………………………………………3 第二節 研究目的………………………………………………………9 第三章 研究材料與方法………………………………………………10 第四章 研究結果………………………………………………………16 第五章 討論……………………………………………………………19 第六章 侷限與展望……………………………………………………22 第七章 論文英文摘要…………………………………………………23 第八章 參考文獻………………………………………………………26 第九章 圖表……………………………………………………………32 表目錄 表一: 受試者之人口統計學資料及臨床特徵…………………………32 表二: 受試者心臟超音波基本資料及比較……………………………33 表三: 舒張性心衰竭與腎素-血管收縮素系統基因多型性之單基座分析………………………………………………………………………34 表四: 舒張性心衰竭與腎素-血管收縮素系統基因多型性不模式下單基因座分析………………………………………………………………35 表五: 舒張性心衰竭與腎素-血管收縮素系統基因多型性多變項回歸分析後(含性別,年齡,藥物,高血壓,糖尿病,左心室質量指數)之單基因座分析………………………………………………………36 表六: 血管收縮素轉化酵素多基因座單倍型分析及實驗組與對照組間之比較…………………………………………………………………37 圖目錄 圖一: 不同嚴重程度的舒張性心衰竭二尖瓣流入血流在心臟都卜勒超音波下的變化……………………………………………………………38 圖二: 在第一對染色體上之血管收縮素原基因多型性與第十七對染色體上的血管收縮素轉化酵素基因插入缺失多型性之間的相關…………………………………………………………………39 | |
dc.language.iso | zh-TW | |
dc.title | 腎素-血管收縮素系統基因多型性與舒張性心衰竭 | zh_TW |
dc.title | Renin-Angiotensin System Gene Polymorphisms
and Diastolic Heart Failure | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 黃瑞仁(Juey-Jen Hwang),許寬立(Kwan-Li Hsu),楊偉勛(Wei-Shiung Yang) | |
dc.subject.keyword | 舒張性心衰竭,基因,多型性,腎素,血管收縮素,接受器, | zh_TW |
dc.subject.keyword | Haplotypes,Diastolic heart failure,genetic,polymorphism,angiotensinogen,angiotensin-converting enzyme,receptors,angiotensin II, | en |
dc.relation.page | 39 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-06-27 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 460.92 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。